These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 1987488)
41. Gene therapy for haematopoietic and lymphoid disorders. Kohn DB Clin Exp Immunol; 1997 Jan; 107 Suppl 1():54-7. PubMed ID: 9020937 [TBL] [Abstract][Full Text] [Related]
42. Ethical considerations in allogeneic hematopoietic cell transplantation for children with slowly fatal conditions. Mullen CA; Chan KW Bone Marrow Transplant; 2000 Nov; 26(9):1030-1. PubMed ID: 11100287 [No Abstract] [Full Text] [Related]
43. Gene transfer into hematopoietic progenitor and stem cells: progress and problems. Dunbar CE; Emmons RV Stem Cells; 1994 Nov; 12(6):563-76. PubMed ID: 7881358 [TBL] [Abstract][Full Text] [Related]
44. Progress and prospects: gene transfer into embryonic stem cells. Yates F; Daley GQ Gene Ther; 2006 Oct; 13(20):1431-9. PubMed ID: 17016468 [TBL] [Abstract][Full Text] [Related]
45. [Development of gene therapy for hematopoietic stem cell using viral vectors]. Dong WJ; Zu ZX; Liu DP; Liang CC Yi Chuan Xue Bao; 2003 Apr; 30(4):382-8. PubMed ID: 12812066 [TBL] [Abstract][Full Text] [Related]
46. [The basic aspects and principles of gene therapy]. Friedberg V Gynakologe; 1994 Oct; 27(5):273-7. PubMed ID: 7821858 [No Abstract] [Full Text] [Related]
47. Gene therapy: a genetic era of technological development to treat pediatric genetic disorders. Mele C J Pediatr Nurs; 2012 Apr; 27(2):180-3. PubMed ID: 22210195 [No Abstract] [Full Text] [Related]
48. Somatic gene therapy. Current status and future prospects. Williams DA; Orkin SH J Clin Invest; 1986 Apr; 77(4):1053-6. PubMed ID: 3514670 [No Abstract] [Full Text] [Related]
49. Prospects, realities, and safety concerns of gene therapy. Radmer A; Bodurtha J Va Med Q; 1992; 119(2):98-100. PubMed ID: 1562625 [No Abstract] [Full Text] [Related]
51. Genetic correction of hereditary disease. Johnson MP; Drugan A; Miller OJ; Evans MI Fetal Ther; 1989; 4 Suppl 1():28-39. PubMed ID: 2577303 [TBL] [Abstract][Full Text] [Related]
52. The good news--and the bad--about gene therapy prospects. Marx JL Science; 1987 Apr; 236(4797):29-30. PubMed ID: 3470944 [No Abstract] [Full Text] [Related]
53. Treatment of genetic defects in hematopoietic cell function by gene transfer. Karlsson S Blood; 1991 Nov; 78(10):2481-92. PubMed ID: 1824245 [No Abstract] [Full Text] [Related]
54. Scope and limitations of gene therapy. Weatherall DJ Br Med Bull; 1995 Jan; 51(1):1-11. PubMed ID: 7767636 [TBL] [Abstract][Full Text] [Related]
55. Fetal somatic gene therapy--a preventive approach to the treatment of genetic disease: the case for. Coutelle C; Themis M; Schneider H; Kiserud T; Cook T; Douar AM; Hanson M; Pavirani A; Rodeck C Ernst Schering Res Found Workshop; 2001; (33):99-114. PubMed ID: 11105256 [No Abstract] [Full Text] [Related]
57. The prospects for gene therapy in humans. Morrow JF Ann N Y Acad Sci; 1976; 265():13-21. PubMed ID: 1066078 [No Abstract] [Full Text] [Related]
58. Human gene therapy: possibilities and limitations. Müller H Experientia; 1987 Apr; 43(4):375-8. PubMed ID: 3552717 [TBL] [Abstract][Full Text] [Related]
59. Identification of disease genes and somatic gene therapy: an overview and prospects for the aged. Patel PI J Gerontol; 1993 May; 48(3):B80-5. PubMed ID: 8482809 [TBL] [Abstract][Full Text] [Related]